161 related articles for article (PubMed ID: 22814143)
1. A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndrome.
Torimoto K; Okada Y; Arao T; Mori H; Tanaka Y
Endocr J; 2012; 59(12):1051-6. PubMed ID: 22814143
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Fanconi Syndrome Induced by Zoledronic Acid in a Metastatic Colorectal Cancer Patient].
Okagawa Y; Sato Y; Onuma H; Osuga T; Hayashi T; Sato T; Miyanishi K; Kobune M; Takimoto R; Kato J
Gan To Kagaku Ryoho; 2015 Jul; 42(7):867-70. PubMed ID: 26197752
[TBL] [Abstract][Full Text] [Related]
3. A case of acquired Fanconi syndrome induced by zoledronic acid.
Yoshinami T; Yagi T; Sakai D; Sugimoto N; Imamura F
Intern Med; 2011; 50(9):1075-9. PubMed ID: 21532237
[TBL] [Abstract][Full Text] [Related]
4. Tubulointerstitial nephritis and uveitis with Fanconi syndrome in a patient with ankylosing spondylitis.
Wen YK
Clin Nephrol; 2009 Oct; 72(4):315-8. PubMed ID: 19825339
[TBL] [Abstract][Full Text] [Related]
5. Fanconi Syndrome Associated with Long-term Treatment with Zoledronate.
Katsunuma R; Mitsumoto K; Mizumoto A; Hirai Y; Nakauchi C; Uzu T
Intern Med; 2023 Jul; 62(14):2103-2105. PubMed ID: 36450467
[TBL] [Abstract][Full Text] [Related]
6. Kidney failure caused by tubular intersticial intersticial nephropathy with Fanconi syndrome after treatment with zoledronic acid.
Gutiérrez Sánchez MJ; Petkov Stoyanov V; Pedraza Cezón L; Martín Navarro JA
Nefrologia; 2017; 37(6):660-661. PubMed ID: 29122217
[No Abstract] [Full Text] [Related]
7. A report of three cases of patients with tubulointerstitial nephritis with IgM-positive plasma cells, treatment, and serum-IgM as a sensitive marker for relapse.
Akagi R; Ishii A; Kaneko K; Kondo N; Yokoi H; Matsubara T; Minamiguchi S; Kanno Y; Yanagita M
BMC Nephrol; 2023 Jul; 24(1):201. PubMed ID: 37403069
[TBL] [Abstract][Full Text] [Related]
8. Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis.
Min HK; Kim EO; Lee SJ; Chang YK; Suh KS; Yang CW; Kim SY; Hwang HS
BMC Nephrol; 2013 Jan; 14():13. PubMed ID: 23320835
[TBL] [Abstract][Full Text] [Related]
9. Adult-onset acute tubulointerstitial nephritis and uveitis with Fanconi syndrome. Case report and review of the literature.
Koike K; Lida S; Usui M; Matsumoto Y; Fukami K; Ueda S; Tamaki K; Kato S; Okuda S
Clin Nephrol; 2007 Apr; 67(4):255-9. PubMed ID: 17474563
[TBL] [Abstract][Full Text] [Related]
10. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
Moore MM; Beith JM
Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
[No Abstract] [Full Text] [Related]
11. Severe Hypophosphatemia as the Initial Presentation of Renal Fanconi's Syndrome and Distal Renal Tubular Acidosis Related to Zoledronic Acid: A Case Report and Literature Review.
Wu Y; Ma T; Yu X; Su T
Kidney Blood Press Res; 2023; 48(1):18-27. PubMed ID: 36412607
[TBL] [Abstract][Full Text] [Related]
12. Pembrolizumab-induced Acute Tubulointerstitial Nephritis Accompanying Fanconi Syndrome and Type 1 Renal Tubular Acidosis.
Fujioka H; Kakeshita K; Imamura T; Arisawa Y; Yokoyama S; Yamazaki H; Koike T; Minamisaka T; Hirabayashi K; Kinugawa K
Intern Med; 2024 Feb; 63(4):533-539. PubMed ID: 37380456
[TBL] [Abstract][Full Text] [Related]
13. Tubulo-interstitial nephritis caused by sodium valproate.
Yoshikawa H; Watanabe T; Abe T
Brain Dev; 2002 Mar; 24(2):102-5. PubMed ID: 11891102
[TBL] [Abstract][Full Text] [Related]
14. A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.
Yamaguchi S; Maruyama T; Wakino S; Tokuyama H; Hashiguchi A; Tada S; Homma K; Monkawa T; Thomas J; Miyashita K; Kurihara I; Yoshida T; Konishi K; Hayashi K; Hayashi M; Itoh H
BMC Nephrol; 2015 Nov; 16():187. PubMed ID: 26554665
[TBL] [Abstract][Full Text] [Related]
15. TINU-associated Fanconi syndrome: a case report and review of literature.
Vô B; Yombi JC; Aydin S; Demoulin N; Yildiz H
BMC Nephrol; 2018 Oct; 19(1):274. PubMed ID: 30340545
[TBL] [Abstract][Full Text] [Related]
16. Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Tunn UW; Stenzl A; Schultze-Seemann W; Strauss A; Kindler M; Miller K; Wirth MP; Zantl N; Schulze M; May C; Ruebel A; Birkholz K; Gruenwald V
Can J Urol; 2012 Jun; 19(3):6261-7. PubMed ID: 22704310
[TBL] [Abstract][Full Text] [Related]
17. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome].
Rogowska E; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):289-95. PubMed ID: 15738605
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic Acid-Associated Fanconi Syndrome in Patients With Cancer.
Portales-Castillo I; Mount DB; Nigwekar SU; Yu EW; Rennke HG; Gupta S
Am J Kidney Dis; 2022 Oct; 80(4):555-559. PubMed ID: 35219759
[TBL] [Abstract][Full Text] [Related]
19. Tubulointerstitial nephritis and uveitis syndrome (TINU) with Fanconi's syndrome.
Yao YH; Lin CC; Chung YM; Yang AH; Li SY; Lin CC; Lin YP; Yang WC; Yang CY
Clin Nephrol; 2011 Feb; 75 Suppl 1():75-8. PubMed ID: 21269599
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
Hayashi K; Aono M; Shintani K; Kazuki K
Anticancer Res; 2014 Mar; 34(3):1245-9. PubMed ID: 24596367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
